Authors: BOSCHELLI DH WU ZP KLUTCHKO SR SHOWALTER HDH HAMBY JM LU GH MAJOR TC DAHRING TK BATLEY B PANEK RL KEISER J HARTL BG KRAKER AJ KLOHS WD ROBERTS BJ PATMORE S ELLIOTT WL STEINKAMPF R BRADFORD LA HALLAK H DOHERTY AM

Citation: Dh. Boschelli et al., SYNTHESIS AND TYROSINE KINASE INHIBITORY ACTIVITY OF A SERIES OF 2-AMINO-8H-PYRIDO[2,3-D]PYRIMIDINES - IDENTIFICATION OF POTENT, SELECTIVE PLATELET-DERIVED GROWTH-FACTOR RECEPTOR TYROSINE KINASE INHIBITORS, Journal of medicinal chemistry, 41(22), 1998, pp. 4365-4377

Authors: KLUTCHKO SR HAMBY JM BOSCHELLI DH WU ZP KRAKER AJ AMAR AM HARTL BG SHEN C KLOHS WD STEINKAMPF RW DRISCOLL DL NELSON JM ELLIOTT WL ROBERTS BJ STONER CL VINCENT PW DYKES DJ PANEK RL LU GH MAJOR TC DAHRING TK HALLAK H BRADFORD LA SHOWALTER HDH DOHERTY AM

Citation: Sr. Klutchko et al., 2-SUBSTITUTED AMINOPYRIDO[2,3-D]PYRIMIDIN-7(8H) ONES - STRUCTURE-ACTIVITY-RELATIONSHIPS AGAINST SELECTED TYROSINE KINASES AND IN-VITRO AND IN-VIVO ANTICANCER ACTIVITY, Journal of medicinal chemistry, 41(17), 1998, pp. 3276-3292

Authors: BARKSDALE CM BURGER PJ NORDBLOM GD COOK JA KIRKISH LS MICHNIEWICZ BM DUDECK RC HODGES JC KLUTCHKO SR CONNOLLY CJC

Citation: Cm. Barksdale et al., DEVELOPMENT AND VALIDATION OF A RADIOIMMUNOASSAY FOR THE ORALLY-ACTIVE RENIN INHIBITOR CI-992 IN CYNOMOLGUS MONKEY AND HUMAN PLASMA, Journal of clinical ligand assay, 20(3), 1997, pp. 251-257

Authors: PANEK RL LU GH KLUTCHKO SR BATLEY BL DAHRING TK HAMBY JM HALLAK H DOHERTY AM KEISER JA

Citation: Rl. Panek et al., IN-VITRO PHARMACOLOGICAL CHARACTERIZATION OF PD-166285, A NEW NANOMOLAR POTENT AND BROADLY ACTIVE PROTEIN-TYROSINE KINASE INHIBITOR, The Journal of pharmacology and experimental therapeutics, 283(3), 1997, pp. 1433-1444